Table 2.
The positive rate comparison of HCRP, MMP9, and TCM syndrome in different hypertensive subgroups.
| Cardiovascular and cerebrovascular infarction events | |||||
|---|---|---|---|---|---|
| No cases (%) | Acute cases (%) | Obsolete cases (%) | χ 2 | P | |
| Cases | 182 | 48 | 38 | — | — |
| Syndrome of wind | 27 (14.8%) | 23 (47.9%) | 5 (13.2%) | 26.957 | 0.000 |
| Syndrome of heat | 26 (14.3%) | 10 (20.8%) | 5 (13.2%) | 1.413 | 0.493 |
| Phlegm turbidity | 12 (6.6%) | 26 (54.2%) | 3 (7.9%) | 68.212 | 0.000 |
| Blood stasis | 135 (74.2%) | 37 (77.1%) | 30 (78.9%) | 0.478 | 0.788 |
| Syndrome of deficiency | 45 (24.7%) | 2 (4.2%) | 11 (28.9%) | 10.860 | 0.004 |
| HCRP ≥ 3 mg/L | 45 (24.7%) | 31 (64.6%) | 12 (31.6%) | 27.393 | 0.000 |
| MMP9 ≥ 140 ng/mL | 108 (59.3%) | 39 (81.3%) | 34 (89.5%) | 18.034 | 0.000 |